Search Results - Rupert Bartsch

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Denosumab for the treatment of bone metastases in breast cancer: evidence and opinion by Guenther G. Steger, Rupert Bartsch

    Published in Therapeutic Advances in Medical Oncology (2011-09-01)
    Get full text
    Article


  2. 2

    Characterization of HER2 Expression Levels, Including HER2-Ultralow, in a Retrospective Male Breast Cancer Cohort by Maximilian Marhold, Alexa Binder, Zsuzsanna Bago-Horvath, Stefan Konrad, Daniela Kauer-Dorner, Rupert Bartsch, Ruth Exner, Kerstin Wimmer

    Published in Life (2026-06-01)
    Get full text
    Article


  3. 3

    Indocyanine green video angiography predicts outcome of extravasation injuries. by Werner Haslik, Ursula Pluschnig, Günther G Steger, Christoph C Zielinski, K F Schrögendorfer, Jakob Nedomansky, Rupert Bartsch, Robert M Mader

    Published in PLoS ONE (2014-01-01)
    Get full text
    Article


  4. 4

    The role of ADAMTS‐13 and von Willebrand factor in cancer patients: Results from the Vienna Cancer and Thrombosis Study by Hanna L. Obermeier, Julia Riedl, Cihan Ay, Silvia Koder, Peter Quehenberger, Rupert Bartsch, Alexandra Kaider, Christoph C. Zielinski, Ingrid Pabinger

    Get full text
    Article


  5. 5

    Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in Austria by Christine Deutschmann, Rupert Bartsch, Christian F Singer, Daphne Gschwantler-Kaulich, Michael Seifert, Carmen Leser, Maximilian Marhold, Zsuzsanna Bago-Horvath, Georg Pfeiler

    Published in BMC Cancer (2022-10-01)
    Get full text
    Article


  6. 6

    Comparison of T-DXd-associated pulmonary toxicity in real-world settings and clinical trials by Simon Udovica, Rupert Bartsch, Christian F. Singer, Clemens Leitgeb, Maximilian Marhold, Christian Peters-Engl, Verena Sagaster, Maximilian Hochmair, Muna Ferner, Wolfgang Hilbe, Kathrin Strasser-Weippl

    Published in npj Breast Cancer (2026-04-01)
    Get full text
    Article


  7. 7

    Emergence of immune-related adverse events correlates with pathological complete response in patients receiving pembrolizumab for early triple-negative breast cancer by Maximilian Marhold, Simon Udovica, Anna Halstead, Mona Hirdler, Muna Ferner, Kerstin Wimmer, Zsuzsanna Bago-Horvath, Ruth Exner, Florian Fitzal, Kathrin Strasser-Weippl, Tim Robinson, Rupert Bartsch

    Published in OncoImmunology (2023-12-01)
    Get full text
    Article


  8. 8

    Prevalence and biopsychosocial indicators of fatigue in cancer patients by Elisabeth L. Zeilinger, Irina Zrnic‐Novakovic, Claudia Oppenauer, Matthäus Fellinger, Matthias Knefel, Matthias Unseld, Theresa Wagner, Simone Lubowitzki, Rupert Bartsch, Sabine Zöchbauer‐Müller, Markus Raderer, Philipp B. Staber, Peter Valent, Alexander Gaiger

    Published in Cancer Medicine (2024-06-01)
    Get full text
    Article


  9. 9

    Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression by Eva Valentina Klocker, Samantha Hasenleithner, Rupert Bartsch, Simon P. Gampenrieder, Daniel Egle, Christian F. Singer, Gabriel Rinnerthaler, Michael Hubalek, Katja Schmitz, Zsuzsanna Bago‐Horvath, Andreas Petzer, Sonja Heibl, Ellen Heitzer, Marija Balic, Michael Gnant

    Published in Molecular Oncology (2025-07-01)
    Get full text
    Article


  10. 10

    Clinical impact of single-gene vs. panel sequencing in advanced HR + /HER2− breast cancer: insights and implications by Eva Valentina Klocker, Nina Dobrić, Ricarda Graf, Christine Beichler, Dominik Hlauschek, Christoph Suppan, Lara Pancheri, Daniel Egle, Carmen Albertini, Rupert Bartsch, Angelika Martina Starzer, Philipp Jakob Jost, Gabriel Rinnerthaler, Ellen Heitzer, Nadia Dandachi, Marija Balic

    Published in npj Breast Cancer (2025-08-01)
    Get full text
    Article


  11. 11

    Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients by Kerstin Wimmer, Monika Sachet, Cristiano Ramos, Sophie Frantal, Hanna Birnleitner, Christine Brostjan, Ruth Exner, Martin Filipits, Zsuzsanna Bago-Horvath, Margaretha Rudas, Rupert Bartsch, Michael Gnant, Christian F. Singer, Marija Balic, Daniel Egle, Rudolf Oehler, Florian Fitzal

    Get full text
    Article


  12. 12

    Monocyte subsets in breast cancer patients under treatment with aromatase inhibitor and mucin-1 cancer vaccine by Viktoria Knöbl, Lukas Maier, Stefan Grasl, Carmen Kratzer, Felix Winkler, Vanessa Eder, Hubert Hayden, Maria Amparo Sahagun Cortez, Monika Sachet, Rudolf Oehler, Sophie Frantal, Christian Fesl, Karin Zehetner, Georg Pfeiler, Rupert Bartsch, Florian Fitzal, Christian F. Singer, Martin Filipits, Michael Gnant, Christine Brostjan

    Published in Journal of Translational Medicine (2024-10-01)
    Get full text
    Article


  13. 13

    Long-term prognostic value of ctDNA in early breast cancer: insights from the neoadjuvant ABCSG-34 Trial by Daniel Egle, Dominik Hlauschek, Simon Peter Gampenrieder, Gabriel Rinnerthaler, Christian Singer, Georg Pfeiler, Rupert Bartsch, Gregor Huber, Angelika Pichler, Edgar Petru, Zsuzsanna Bago-Horvath, Anna-Sophia Kermanidis, Christian Fesl, Qing Zhou, Ricarda Graf, Sabrina Hammer, Nadia Dandachi, Martin Filipits, Michael Gnant, Ellen Heitzer, Marija Balic

    Published in npj Breast Cancer (2026-04-01)
    Get full text
    Article


  14. 14

    The cancer survival index—A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies by Alexander Gaiger, Simone Lubowitzki, Katharina Krammer, Elisabeth L. Zeilinger, Andras Acel, Olivera Cenic, Andrea Schrott, Matthias Unseld, Anahita Paula Rassoulian, Cathrin Skrabs, Peter Valent, Heinz Gisslinger, Christine Marosi, Matthias Preusser, Gerald Prager, Gabriela Kornek, Robert Pirker, Günther G. Steger, Rupert Bartsch, Markus Raderer, Ingrid Simonitsch‐Klupp, Renate Thalhammer, Christoph Zielinski, Ulrich Jäger

    Published in Cancer Medicine (2022-09-01)
    Get full text
    Article


  15. 15

    HER2 and HER3 expression during neoadjuvant treatment of HER2‐negative early breast cancer: potential for biomarker‐driven sequencing of T‐DXd and HER3‐DXd by Christian Fridolin Singer, Stephan Wenzel Jahn, Dominik Hlauschek, Ulrike Maria Heber, Charlotte Mang‐Manger, Daniel Egle, Marija Balic, Angelika Pichler, Georg Pfeiler, Stephanie Kacerovsky‐Strobl, Christoph Suppan, Magdalena Ritter, Edgar Petru, Richard Greil, Zsuzsanna Bago‐Horvath, Christine Deutschmann, Günther Georg Steger, Michael Seifert, Florian Fitzal, Rupert Bartsch, Anu Santhanagopal, Jana Machacek‐Link, Dalila Sellami, Magdalena Schwarz, Christian Fesl, Lidija Sölkner, Stephen Esker, Martin Filipits, Michael Gnant, the Austrian Breast and Colorectal Cancer Study Group

    Published in Cancer Communications (2025-04-01)
    Get full text
    Article


Search Tools: